Stock Research: Camurus

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Camurus

OM:CAMX SE0007692850
65
  • Value
    84
  • Growth
    95
  • Safety
    Safety
    6
  • Combined
    76
  • Sentiment
    46
  • 360° View
    360° View
    65
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Camurus AB is a Sweden-based pharmaceutical and biotechnology company focused on specialty medicines for severe and chronic diseases. They operate in the pharmaceutical and biotechnology industries, developing products for opioid dependence, pain, cancer, and endocrine diseases. The company is based in Sweden and has legal entities in the US, Germany, UK, Finland, Norway, France, Australia, Spain, Denmark, Austria, and the Netherlands. In the last fiscal year, the company had a market cap of $4186 million, profits of $157 million, revenue of $169 million, and 256 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 65 (better than 65% compared with alternatives), overall professional sentiment and financial characteristics for the stock Camurus are above average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Camurus. The consolidated Growth Rank has a good rank of 95, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 95% of competitors in the same industry. In addition, the consolidated Safety Rank has a safer rank of 84 which means that the company has a financing structure that is safer than 84% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the consolidated Value Rank has a less desirable rank of 6 which means that the share price of Camurus is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is higher than for 94% of alternative stocks in the same industry. The consolidated Sentiment Rank also has a low rank of 46, which means that professional investors are more pessimistic about the stock than for 54% of alternative investment opportunities. ...read more

more
Index
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
6 4 1 8
Growth
95 100 95 91
Safety
Safety
84 96 80 34
Sentiment
46 54 76 82
360° View
360° View
65 57 86 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
84 69 78 95
Opinions Change
15 50 72 50
Pro Holdings
n/a 45 53 64
Market Pulse
39 48 39 31
Sentiment
46 54 76 82
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
6 4 1 8
Growth
95 100 95 91
Safety Safety
84 96 80 34
Combined
76 69 72 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
19 14 6 25
Price vs. Earnings (P/E)
7 3 5 31
Price vs. Book (P/B)
3 3 5 12
Dividend Yield
1 1 1 1
Value
6 4 1 8
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
88 96 73 90
Profit Growth
98 98 100 78
Capital Growth
98 85 22 93
Stock Returns
47 86 100 20
Growth
95 100 95 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
90 92 90 77
Refinancing
43 25 27 36
Liquidity
92 100 79 8
Safety Safety
84 96 80 34

Similar Stocks

Discover high‑ranked alternatives to Camurus and broaden your portfolio horizons.

Ipsen

ENXTPA:IPN
Country: France
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

thyssenkrupp

XTRA:TKA
Country: Germany
Industry: Steel
Size: X-Large
Full Stock Analysis

Embracer Group

OM:EMBRAC B
Country: Sweden
Industry: Interactive Home Entertainment
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.